Trinity Biotech
TRIB
$1.56
Share price
-1.27%
Change (1 day)
62.50%
Change (1 year)
Categories
P/S ratio for Trinity Biotech (TRIB)
P/S ratio as of May 2024 (TTM): 0.2434
According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.243412. At the end of 2023 the company had a P/S ratio of 0.4571.
P/S ratio history for Trinity Biotech from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.4571 | -21.44% |
| 2022 | 0.5819 | 80.99% |
| 2021 | 0.3215 | -58.83% |
| 2020 | 0.7809 | 226.95% |
| 2019 | 0.2388 | -51.58% |
| 2018 | 0.4933 | -54.18% |
| 2017 | 1.08 | -32.92% |
| 2016 | 1.61 | -42.93% |
| 2015 | 2.81 | -28.56% |
| 2014 | 3.94 | -38.56% |
| 2013 | 6.41 | 63.51% |
| 2012 | 3.92 | 41.29% |
| 2011 | 2.77 | 33.09% |
| 2010 | 2.08 | 210.58% |
| 2009 | 0.6710 | 216.41% |
| 2008 | 0.2121 | -82.03% |
| 2007 | 1.18 | -12.04% |
| 2006 | 1.34 | 6.54% |
| 2005 | 1.26 | 144.61% |
| 2004 | 0.5147 | -47.16% |
| 2003 | 0.9741 | 272% |
| 2002 | 0.2619 | -35.69% |
| 2001 | 0.4072 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.51 | 1,754.74% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 5.30 | 2,078.27% | 🇺🇸 USA |
 Danaher DHR | 8.74 | 3,491.69% | 🇺🇸 USA |
 QuidelOrtho QDEL | 0.9566 | 293.00% | 🇺🇸 USA |
 OraSure Technologies OSUR | 0.8974 | 268.68% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | 0.3457 | 42.02% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 3.11 | 1,178.22% | 🇺🇸 USA |